摘要
目的了解茶碱对支气管哮喘患者血小板活化因子(PAF)受体mRNA表达的影响。方法采用逆转录多聚酶链反应(RT-PCR)技术检测了支气管哮喘患者及健康成人外周淋巴细胞PAF受体mRNA的表达水平,探讨了小剂量茶碱对哮喘患者外周淋巴细胞PAF受体mRNA表达的影响。结果(1)被检测的20例健康成人中只有8例其外周淋巴细胞PAF受体的cDNA可被扩增出来,而被检测的21例哮喘患者均可获得cDNA片断;(2)服用小剂量茶碱1wk后,哮喘患者PAF受体mRNA表达量(以“闪烁计数min-1”表示,下同)与给药前的表达量相比无明显变化(P>0.05),服用2wk后,哮喘患者PAF受体mRNA表达量由给药前的86408±7462减少至68927±5886(P<0.05),服用3wk后减少至56720±4866(与给药前比较,P<0.01),接近健康人的表达量49688±5438。结论连续服用小剂量茶碱可抑制外周淋巴细胞PAF受体mRNA的表达。
AIM To study the effects of small dose protheo on level of plateletactivating factor (PAF) receptor mRNA expression in asthma blood lymphatic cells. METHODS To use reverse transcription of RNA followed by polymerase chain reaction (RTPCR) technique. RESULTS (1) cDNA region of PAF receptor in blood lymphatic cells was obtained from only 8 cases of 20 healthy adults but all 21 cases of asthmatic patients by RTPCR. (2) Small dose protheo (200 μg, three times a day) was used for asthma for one week, the level of PAF receptor mRNA expression in blood lymphatic cells showed no change vs before (P>005), this level was reduced for two weeks (P<005) and markedly reduced vs before (P<001) for three weeks, close to that of healthy adult. CONCLUSIONS Small dose protheo may inhibit PAF receptor mRNA expression in asthma blood lymphatic cells.
出处
《中国药理学通报》
CAS
CSCD
北大核心
1998年第1期30-32,共3页
Chinese Pharmacological Bulletin
基金
广东省重点实验室资助
关键词
哮喘
药物疗法
茶碱
血小板活化因子
mRNA
受体
protheo
asthma
polymerase chain reaction
plateletactivating factor
receptor